Gaurav Kumar Pandey

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Dna Damage Response

Patient Reported

Top Venues

British journal of cancer

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Nick Landman, Danielle Hulsman, Jitendra Badhai, Jawahar Kopparam, Julian Puppe, Gaurav Kumar Pandey, Maarten van Lohuizen
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma. British journal of cancer 130 (11) (2024)
Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey, Ji-Ying Song, Danielle Hulsman, Oscar Krijgsman, Gayathri Chandrasekaran, Anton Berns, Maarten van Lohuizen
Combined inhibition of EZH2 and FGFR is synergistic in BAP1- deficient malignant mesothelioma. Cancer research communications (2023)
Gaurav Kumar Pandey, Chandrasekhar Kanduri
Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways. Cancers 14 (19) (2022)